News & Updates

Show Multimedia Only

Physically active women less reliant on pain meds for headache

05 Mar 2022 by

A cross-sectional study by the German Migraine and Headache Society reports a lower use of analgesics among physically active women prone to headaches vs physically inactive counterparts.

Physically active women less reliant on pain meds for headache

05 Mar 2022

Sustained-release noninferior to immediate-release pregabalin formulation

04 Mar 2022

The novel once-daily sustained-release (SR) pregabalin formulation is safe and as good as the twice-daily immediate-release (IR) formulation at reducing peripheral neuropathic pain, according to the results of a phase III trial.

Sustained-release noninferior to immediate-release pregabalin formulation

04 Mar 2022

Magnesium oxide, riboflavin may reduce episodic migraine during pregnancy

04 Mar 2022 by

The use of magnesium oxide either alone or in combination with riboflavin may help prevent episodic migraines during pregnancy, according to a study presented at SMFM 2022.

Magnesium oxide, riboflavin may reduce episodic migraine during pregnancy

04 Mar 2022

Electronic nose could sniff out Parkinson’s disease

03 Mar 2022 by

An artificially intelligent olfactory system has the potential to detect Parkinson’s disease through the odour profile of sebum, as shown in a study.

Electronic nose could sniff out Parkinson’s disease

03 Mar 2022

Full endoscopic on par with open discectomy for sciatica

03 Mar 2022 by

Percutaneous transforaminal endoscopic discectomy (PTED) is as effective as open microdiscectomy in alleviating leg pain caused by lumbar disc herniation, results of a trial have shown. PTED can thus be considered as an alternative to open microdiscectomy in the treatment of sciatica.

Full endoscopic on par with open discectomy for sciatica

03 Mar 2022

Original New Drug Application Approvals by US FDA (16 - 28 February 2022)

03 Mar 2022

New drug applications approved by US FDA as of 16-28 February 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 28 February 2022)

03 Mar 2022

Wearables detect seizures, help prevent related injuries

03 Mar 2022 by

The use of wearable devices is feasible for the automated seizure detection in the home environment, leading to better care outcomes, such as fewer seizure-related injuries and more accurate seizure diaries, according to a recent study.

Wearables detect seizures, help prevent related injuries

03 Mar 2022

Migraine drug yields preventive benefits across the board in episodic, chronic migraine

02 Mar 2022 by

Eptinezumab reduces migraine days for both episodic and chronic migraine patients, and the drug’s efficacy and safety profile are independent of age, sex, and body mass index, as shown in a study.

Migraine drug yields preventive benefits across the board in episodic, chronic migraine

02 Mar 2022

Quantitative sensory testing reliable for pain threshold, tolerance assessment

02 Mar 2022

Quantitative sensory testing (QST) yields reliable measures of pain threshold and tolerance, reveals a new study. However, measurements for sensitivity to changes in temperature are less reliable and may be affected by time and other contextual factors.

Quantitative sensory testing reliable for pain threshold, tolerance assessment

02 Mar 2022

Mucolytics, ICS/LABA combinations cut stroke risk among COPD patients with allied conditions

02 Mar 2022

Patients with chronic obstructive pulmonary disease (COPD) and allied conditions are at heightened risk of stroke, but treatment with mucolytic agents and the combination of inhaled corticosteroids (ICS) plus long-acting β2-agonists (LABA) may protect against the risk, as shown in a study.

Mucolytics, ICS/LABA combinations cut stroke risk among COPD patients with allied conditions

02 Mar 2022

News & Updates

Filter by Specialty:

Specialty:

Physically active women less reliant on pain meds for headache

Physically active women less reliant on pain meds for headache

Sustained-release noninferior to immediate-release pregabalin formulation

Sustained-release noninferior to immediate-release pregabalin formulation

Magnesium oxide, riboflavin may reduce episodic migraine during pregnancy

Magnesium oxide, riboflavin may reduce episodic migraine during pregnancy

Electronic nose could sniff out Parkinson’s disease

Electronic nose could sniff out Parkinson’s disease

Full endoscopic on par with open discectomy for sciatica

Full endoscopic on par with open discectomy for sciatica

Original New Drug Application Approvals by US FDA (16 - 28 February 2022)

Original New Drug Application Approvals by US FDA (16 - 28 February 2022)

Wearables detect seizures, help prevent related injuries

Wearables detect seizures, help prevent related injuries

Migraine drug yields preventive benefits across the board in episodic, chronic migraine

Migraine drug yields preventive benefits across the board in episodic, chronic migraine

Quantitative sensory testing reliable for pain threshold, tolerance assessment

Quantitative sensory testing reliable for pain threshold, tolerance assessment

Mucolytics, ICS/LABA combinations cut stroke risk among COPD patients with allied conditions

Mucolytics, ICS/LABA combinations cut stroke risk among COPD patients with allied conditions